Insider Buy/Sell Details for the Biotechnology Industry — Last 30 Days
Ratio0.2:1
Daily Buy & Sell Volume
Transactions (947)
NextCure, Inc. (NXTC)
ADAR1 Capital Management, LLC — 10% Owner
Shares
3,553
Price
$5.10
Total Value
$18.10K
Shares Held After
733,270
% of Holdings
0.5%
Scholar Rock Holding Corp (SRRK)
AKKARAJU SRINIVAS — Director
Shares
97,982
Price
$41.59
Total Value
$4.08M
Shares Held After
723,020
% of Holdings
13.6%
Scholar Rock Holding Corp (SRRK)
AKKARAJU SRINIVAS — Director
Shares
48,988
Price
$41.59
Total Value
$2.04M
Shares Held After
6,380,517
% of Holdings
0.8%
NextCure, Inc. (NXTC)
ADAR1 Capital Management, LLC — 10% Owner
Shares
1,672
Price
$5.03
Total Value
$8.42K
Shares Held After
729,717
% of Holdings
0.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
806
Price
$592.92
Total Value
$477.89K
Shares Held After
324,443
% of Holdings
0.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
694
Price
$591.60
Total Value
$410.57K
Shares Held After
325,249
% of Holdings
0.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
680
Price
$590.57
Total Value
$401.59K
Shares Held After
325,943
% of Holdings
0.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,280
Price
$589.64
Total Value
$754.74K
Shares Held After
326,623
% of Holdings
0.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,241
Price
$588.47
Total Value
$730.29K
Shares Held After
327,903
% of Holdings
0.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
2,707
Price
$587.54
Total Value
$1.59M
Shares Held After
329,144
% of Holdings
0.8%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,492
Price
$586.54
Total Value
$875.12K
Shares Held After
331,851
% of Holdings
0.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
600
Price
$585.71
Total Value
$351.43K
Shares Held After
333,343
% of Holdings
0.2%
Korro Bio, Inc. (KRRO)
Lynx1 Capital Management LP — 10% Owner
Shares
25,124
Price
$11.75
Total Value
$295.09K
Shares Held After
1,624,789
% of Holdings
1.5%
Adaptive Biotechnologies Corp (ADPT)
RUBINSTEIN JULIE — President and COO
Shares
3,378
Price
$26.30
Total Value
$88.84K
Shares Held After
377,802
% of Holdings
0.9%
Adaptive Biotechnologies Corp (ADPT)
RUBINSTEIN JULIE — President and COO
Shares
8,503
Price
$25.94
Total Value
$220.57K
Shares Held After
381,180
% of Holdings
2.2%
Grace Therapeutics, Inc. (GRCE)
Opaleye Management Inc. — 10% Owner
Shares
66,411
Price
$1.77
Total Value
$117.41K
Shares Held After
3,036,411
% of Holdings
2.2%
Boundless Bio, Inc. (BOLD)
TANG KEVIN — 10% Owner
Shares
9,606
Price
$2.38
Total Value
$22.86K
Shares Held After
3,011,749
% of Holdings
0.3%
Scholar Rock Holding Corp (SRRK)
AKKARAJU SRINIVAS — Director
Shares
1,000
Price
$41.82
Total Value
$41.82K
Shares Held After
625,038
% of Holdings
0.2%
Scholar Rock Holding Corp (SRRK)
AKKARAJU SRINIVAS — Director
Shares
500
Price
$41.82
Total Value
$20.91K
Shares Held After
6,331,529
% of Holdings
0.0%
Scholar Rock Holding Corp (SRRK)
AKKARAJU SRINIVAS — Director
Shares
94,000
Price
$41.31
Total Value
$3.88M
Shares Held After
624,038
% of Holdings
15.1%
Scholar Rock Holding Corp (SRRK)
AKKARAJU SRINIVAS — Director
Shares
47,000
Price
$41.31
Total Value
$1.94M
Shares Held After
6,331,029
% of Holdings
0.7%
NextCure, Inc. (NXTC)
ADAR1 Capital Management, LLC — 10% Owner
Shares
5,626
Price
$4.83
Total Value
$27.17K
Shares Held After
728,045
% of Holdings
0.8%
Opus Genetics, Inc. (IRD)
YERXA BENJAMIN R — Director
Shares
25,520
Price
$3.53
Total Value
$90.13K
Shares Held After
670,917
% of Holdings
3.7%
Opus Genetics, Inc. (IRD)
YERXA BENJAMIN R — Director
Shares
7,669
Price
$3.55
Total Value
$27.24K
Shares Held After
696,437
% of Holdings
1.1%
Opus Genetics, Inc. (IRD)
SCHACHLE JOSEPH K — Chief Operating Officer
Shares
4,767
Price
$3.56
Total Value
$16.99K
Shares Held After
286,673
% of Holdings
1.6%
Opus Genetics, Inc. (IRD)
Magrath George — Director
Shares
9,591
Price
$3.58
Total Value
$34.38K
Shares Held After
2,038,894
% of Holdings
0.5%
Opus Genetics, Inc. (IRD)
Gagnon Robert E. — Chief Financial Officer
Shares
14,000
Price
$3.55
Total Value
$49.65K
Shares Held After
542,375
% of Holdings
2.5%
InMed Pharmaceuticals Inc. (INM)
ADAR1 Capital Management, LLC — 10% Owner
Shares
4
Price
$1.32
Total Value
$5.28
Shares Held After
956,584
% of Holdings
0.0%
Pluri Inc. (PLUR)
Manieu Alexandre Weinstein — Director
Shares
833,334
Price
$1.50
Total Value
$1.25M
Shares Held After
2,083,334
% of Holdings
40.0%
Korro Bio, Inc. (KRRO)
Lynx1 Capital Management LP — 10% Owner
Shares
2,510
Price
$12.11
Total Value
$30.39K
Shares Held After
1,599,665
% of Holdings
0.2%
Adaptive Biotechnologies Corp (ADPT)
RUBINSTEIN JULIE — President and COO
Shares
7,381
Price
$25.28
Total Value
$186.59K
Shares Held After
377,802
% of Holdings
1.9%
Adaptive Biotechnologies Corp (ADPT)
RUBINSTEIN JULIE — President and COO
Shares
4,500
Price
$24.50
Total Value
$110.25K
Shares Held After
385,183
% of Holdings
1.2%
Boundless Bio, Inc. (BOLD)
TANG KEVIN — 10% Owner
Shares
6,234
Price
$2.38
Total Value
$14.84K
Shares Held After
3,002,143
% of Holdings
0.2%
Anixa Biosciences Inc (ANIX)
Titterton Lewis H jr — Director
Shares
8,000
Price
$2.98
Total Value
$23.84K
Shares Held After
1,054,003
% of Holdings
0.8%
PROTHENA CORP PUBLIC LTD CO (PRTA)
SCULLY WILLIAM P — 10% Owner
Shares
50,000
Price
$8.07
Total Value
$403.52K
Shares Held After
1,187,000
% of Holdings
4.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
740
Price
$588.00
Total Value
$435.12K
Shares Held After
324,443
% of Holdings
0.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
542
Price
$586.93
Total Value
$318.11K
Shares Held After
325,183
% of Holdings
0.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
778
Price
$585.99
Total Value
$455.90K
Shares Held After
325,725
% of Holdings
0.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
676
Price
$584.77
Total Value
$395.31K
Shares Held After
326,503
% of Holdings
0.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
427
Price
$583.83
Total Value
$249.30K
Shares Held After
327,179
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,732
Price
$582.78
Total Value
$1.01M
Shares Held After
327,606
% of Holdings
0.5%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,650
Price
$581.82
Total Value
$960.01K
Shares Held After
329,338
% of Holdings
0.5%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,017
Price
$580.78
Total Value
$590.65K
Shares Held After
330,988
% of Holdings
0.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,038
Price
$579.74
Total Value
$601.77K
Shares Held After
332,005
% of Holdings
0.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
700
Price
$578.80
Total Value
$405.16K
Shares Held After
333,043
% of Holdings
0.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
200
Price
$577.68
Total Value
$115.54K
Shares Held After
333,743
% of Holdings
0.1%
AIM ImmunoTech Inc. (AIM)
Equels Thomas K — Director
Shares
31,675
Price
$0.16
Total Value
$5.07K
Shares Held After
189,747
% of Holdings
16.7%
Rapport Therapeutics, Inc. (RAPP)
Sanchez Ramiro — Director
Shares
3,600
Price
$27.35
Total Value
$98.48K
Shares Held After
3,600
% of Holdings
100.0%
Korro Bio, Inc. (KRRO)
Lynx1 Capital Management LP — 10% Owner
Shares
40,000
Price
$11.04
Total Value
$441.46K
Shares Held After
1,597,155
% of Holdings
2.5%
Korro Bio, Inc. (KRRO)
Lynx1 Capital Management LP — 10% Owner
Shares
12,175
Price
$9.68
Total Value
$117.81K
Shares Held After
1,557,155
% of Holdings
0.8%
947 transactions